Medicare Enrolled
Dr. Boris Furman, D.O.
Neuromusculoskeletal Medicine & OMM Physician · Manalapan, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Furman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Furman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Furman
Dr. Boris Furman is a neuromusculoskeletal medicine & omm physician in Manalapan, NJ, with 18 years of NPI registration. Based on federal Medicare data, Dr. Furman performed 2,247 Medicare services across 1,440 unique beneficiaries.
Between the years covered by Open Payments, Dr. Furman received a total of $11,186 from 61 pharmaceutical and/or device companies across 815 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neuromusculoskeletal medicine & omm physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Furman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 8% volume in NJ
$11,186 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,247
Medicare services
Top 8% in NJ for neuromusculoskeletal medicine & omm physician
1,440
Unique beneficiaries
$99
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~125 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
438 | $148 | $308 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
416 | $103 | $251 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
414 | $103 | $229 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
122 | $4 | $29 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
120 | $70 | $200 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
116 | $71 | $195 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
106 | $1 | $15 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
102 | $85 | $249 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
98 | $136 | $399 |
| New patient office visit, complex (60-74 min) | 94 | $181 | $500 |
| Lidocaine HCl injection for IV infusion, 10 mg Administration of a 10 mg dose of lidocaine hydrochloride via intravenous infusion. |
62 | $0 | $18 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
53 | $180 | $548 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 21 | $56 | $250 |
| Psychological or neuropsychological test, first 30 minutes Administration of psychological or neuropsychological testing for the first 30 minutes. |
20 | $33 | $100 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
18 | $100 | $250 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
12 | $50 | $190 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
12 | $85 | $342 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
12 | $41 | $208 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
11 | $42 | $170 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.8% high complexity
6.2% medium
91.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,186
Total received (2018-2024)
Avg $1,598/year across 7 years
Top 7% in NJ for neuromusculoskeletal medicine & omm physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
815
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,106 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$81 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,746
2023
$1,839
2022
$2,119
2021
$1,992
2020
$881
2019
$1,514
2018
$1,095
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$278
Teva Pharmaceuticals USA, Inc.
$214
PFIZER INC.
$208
Lilly USA, LLC
$178
Kyowa Kirin, Inc.
$165
Neurocrine Biosciences, Inc.
$161
Novartis Pharmaceuticals Corporation
$63
Sumitomo Pharma America, Inc.
$60
Eisai Inc.
$50
CATALYST PHARMACEUTICALS, INC.
$47
SCILEX PHARMACEUTICALS INC.
$46
SK Life Science, Inc.
$34
Lundbeck LLC
$33
Otsuka America Pharmaceutical, Inc.
$30
Alnylam Pharmaceuticals Inc.
$28
SPR Therapeutics, Inc
$25
Biogen, Inc.
$24
JAZZ PHARMACEUTICALS INC.
$19
UCB, Inc.
$18
Averitas Pharma Inc.
$18
Alexion Pharmaceuticals, Inc.
$17
Grifols USA, LLC
$16
Octapharma USA, Inc.
$15
Top 3 companies account for 40.1% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$1,107
Teva Pharmaceuticals USA, Inc.
$1,080
Novartis Pharmaceuticals Corporation
$1,075
Lilly USA, LLC
$661
UCB, Inc.
$542
ABBVIE INC.
$541
Kyowa Kirin, Inc.
$524
PFIZER INC.
$417
Neurocrine Biosciences, Inc.
$398
Grifols USA, LLC
$354
Eisai Inc.
$310
Supernus Pharmaceuticals, Inc.
$264
Avanir Pharmaceuticals, Inc.
$235
Amgen Inc.
$229
SK Life Science, Inc.
$221
Janssen Pharmaceuticals, Inc
$218
ACADIA Pharmaceuticals Inc
$214
Sumitomo Pharma America, Inc.
$210
Celgene Corporation
$210
Biohaven Pharmaceutical Holding Company Ltd.
$167
AbbVie Inc.
$157
EISAI INC.
$155
Amneal Pharmaceuticals LLC
$146
Lundbeck LLC
$145
Biohaven Pharmaceuticals, Inc.
$137
Acorda Therapeutics, Inc
$121
Scilex Pharmaceuticals Inc.
$104
Indivior Inc.
$82
Allergan, Inc.
$79
Otsuka America Pharmaceutical, Inc.
$72
Neurelis, Inc.
$69
ARGENX US, INC.
$60
SCILEX PHARMACEUTICALS INC.
$59
GENZYME CORPORATION
$56
Corium, LLC
$49
Alexion Pharmaceuticals, Inc.
$48
CATALYST PHARMACEUTICALS, INC.
$47
Octapharma USA, Inc.
$45
Boston Scientific Corporation
$43
Adamas Pharmaceuticals, Inc.
$41
Assertio Therapeutics, Inc.
$40
IMPEL PHARMACEUTICALS INC.
$39
Almatica Pharma LLC
$38
Abbott Laboratories
$38
Catalyst Pharmaceuticals, Inc.
$29
Alnylam Pharmaceuticals Inc.
$28
Allergan Inc.
$28
Bausch Health US, LLC
$28
SPR Therapeutics, Inc
$25
E.R. Squibb & Sons, L.L.C.
$25
US WorldMeds, LLC
$24
MDD US Operations, LLC
$24
JAZZ PHARMACEUTICALS INC.
$19
Averitas Pharma Inc.
$18
Axsome Therapeutics, Inc.
$15
Orexo US, Inc.
$15
Takeda Pharmaceuticals U.S.A., Inc.
$15
Harmony Biosciences LLC
$14
CSL Behring
$14
Collegium Pharmaceutical, Inc.
$12
Vertical Pharmaceuticals, LLC
$11
Top 3 companies account for 29.2% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aduhelm · Aimovig · Austedo XR · BOTOX · Briviact · CAMBIA · COMIRNATY · COPAXONE · Cambia · ELYXYB · ELYXYB - CELECOXIB · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · EUCRISA · FYCOMPA · Fycompa · GILENYA · GOCOVRI · Gamunex-C · General - DBS · Hizentra · INBRIJA · INFINITY · INGREZZA · KESIMPTA · LEMTRADA · LYRICA · LYVISPAH · Leqembi · MAYZENT · MIGRANAL · MOUNJARO · NAPRELAN · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · ONZETRA Xsail · Ongentys · PANZYGA · PAXLOVID · PLEGRIDY · Ponvory · QULIPTA · QUTENZA · RELEXXII · REXULTI · RYTARY · Rystiggo · SOLIRIS · SPINRAZA · SPRINT PNS System · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · Sunosi · TECFIDERA · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VERCISE · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Wakix · XADAGO · Xadago · ZAVZPRET · ZEPOSIA · ZTLido · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for neuromusculoskeletal medicine & omm physician in NJ.
Geographic Context
Neuromusculoskeletal medicine & omm physicians within 10 mi
6
Per 100K population
0.9
County median income
$122,727
Nearest hospital
CENTRASTATE MEDICAL CENTER
5.2 mi
5.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Furman is a clinical cardiology specialist, with above-average Medicare volume (top 8% in NJ), with low-engagement industry engagement in the top 7% of NJ peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Furman experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Furman performed 438 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Furman receive payments from pharmaceutical companies?
Yes. Dr. Furman received a total of $11,186 from 61 companies across 815 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Furman's costs compare to other neuromusculoskeletal medicine & omm physicians in Manalapan?
Dr. Furman's average Medicare payment per service is $99. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Furman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Neuromusculoskeletal Medicine & Omm Physicians in Manalapan
Browse neuromusculoskeletal medicine & omm physicians in Manalapan ranked by procedure volume and transparency data.
Highest volume
Top Neuromusculoskeletal Medicine & Omm Physicians in NJ
Neuromusculoskeletal medicine & omm physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neuromusculoskeletal Medicine & Omm Physicians in NJ
Which NJ neuromusculoskeletal medicine & omm physicians receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology